Nuzenio

Tradingview Agio

Tradingview Agio entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 9 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Price to sales forward of Agios Pharmaceuticals, Inc. – NASDAQ:AGIO - TradingViewTradingView · Sat, 01 Aug 2026 05:43:18 GMT Agios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $45.38, Implies 39% Upside - TradingViewTradingView · Fri, 31 Jul 2026 07:00:00 GMT AGIO: Q2 2026 delivered $44.7M revenue, strong AQVESME launch, and pipeline progress with ~$1B cash - TradingViewTradingView · Thu, 30 Jul 2026 15:36:57 GMT Agios Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 30 Jul 2026 14:04:28 GMT AGIO: Q2 2026 revenue surged to $44.7M, with strong AQVESME launch and narrowed net loss - TradingViewTradingView · Thu, 30 Jul 2026 11:18:01 GMT AGIO: Q2 2026 revenue tripled year-over-year, fueled by AQVESME launch and robust pipeline progress - TradingViewTradingView · Thu, 30 Jul 2026 11:14:15 GMT Agios Pharmaceuticals reports $44.7M Q2 product revenue, $100.7M net loss, $964.8M cash - TradingViewTradingView · Thu, 30 Jul 2026 10:43:00 GMT Agios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $43.12, Implies 23% Upside - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Sat, 01 Aug 2026 05:43:18 GMTPrice to sales forward of Agios Pharmaceuticals, Inc. – NASDAQ:AGIO - TradingView

Fri, 31 Jul 2026 07:00:00 GMTAgios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $45.38, Implies 39% Upside - TradingView

Thu, 30 Jul 2026 15:36:57 GMTAGIO: Q2 2026 delivered $44.7M revenue, strong AQVESME launch, and pipeline progress with ~$1B cash - TradingView

Thu, 30 Jul 2026 14:04:28 GMTAgios Pharmaceuticals Q2 Earnings Call Highlights - TradingView

Thu, 30 Jul 2026 11:18:01 GMTAGIO: Q2 2026 revenue surged to $44.7M, with strong AQVESME launch and narrowed net loss - TradingView

Thu, 30 Jul 2026 11:14:15 GMTAGIO: Q2 2026 revenue tripled year-over-year, fueled by AQVESME launch and robust pipeline progress - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Agios Pharmaceuticals6 live mentions Inc6 live mentions AQVESME6 live mentions AGIO5 live mentions TradingView TradingView5 live mentions Stock4 live mentions Month Price Target4 live mentions Raised4 live mentions Implies4 live mentions TradingView Agios Pharmaceuticals4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Agio.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.